Metropolis Healthcare board meeting scheduled for May 13, 2026 to approve Q4 and FY26 audited financial results.
Board to consider declaration of second interim dividend for financial year 2025-26.
Trading window closed from April 1 to May 15, 2026 in compliance with insider trading code.